1 Chen C,Ke J,Zhou XE,et al.Structural basis for molecular recognition of folic acid by folate receptors.Nature,2013,500:486-489. 2 Yadav BS,Sharma SC,Patel FD,et al.Gynecologicalcancer as a second malignancy in patients with breast cancer.Int J Gynecol Cancer,2017,27:1298-1304. 3 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin,2018,68:394-424. 4 谢俊玲,沈丹华,杜金荣,等.叶酸受体α在女性生殖系统肿瘤中的研究进展.中国妇产科临床杂,2008,9:312-315. 5 Kelemen LE.The role of folate receptor alpha in cancer development,progression and treatment:cause,consequence or innocent bystander?.Int J Cancer,2006,119:243-250. 6 Koo YJ,Kim TJ,Min KJ,et al.CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer.Tumour Biol,2017,39:1-10. 7 周希彬,邱郑,刘欣欣,等.叶酸受体α与卵巢肿瘤.药物生物技术,2012,19:458-461. 8 Moore RG,Mcmeekin DS,Brown AK,et al.A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.Gynecol Oncol,2009,112:40-46. 9 Kalli KR,Oberg AL,Keeney GL,et al.Folate receptor alpha as a tumor target in epithelial ovarian cancer.Gynecol Oncol,2008,108:619-626. 10 Rubinsak LA,Cohen C,Khanna N,et al.Folate Receptor alpha expression in platinum resistant/refractory ovarian carcinomas and primary endocervical adenocarcinomas.Appl Immunohistochem Mol Morphol,2018,26:567-572. 11 Ke CY,Mathias CJ,Green MA.Folate-receptor-targeted radionuclide imaging agents.Adv Drug Deliv Rev,2004,56:1143-1160. 12 Cristina M,Iontcho RV,Hari KR,et al.Tumor targeting using 67Ga-DOTA-Bz-folate-invest tingations of methodsto improve the tissue distribution of radiofolates.Nucl Med Biol,2011,38:715-723. 13 Siegel BA,Dehdashti F,Mutch DG.et al.Evaluation of 111In-DTPA folate as a receptor-targeted diagnostic agent for ovari an cancer:initialclinical results.J Nucl Med,2003:700-707. 14 庞燕,王海军,冯维贵,等.叶酸受体介导的用于肿瘤显像的放射性分子探针的研究进展.卫生职业教育,2018,36:156-159. 15 Fisher RE,Siegel BA,Edell SL,et al.Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.J Nucl Med,2008,49:899-906. 16 符吉芬,裴雄越,王爱丽.叶酸受体α高表达与浆液性卵巢癌患者生存率的相关性研究.中国现代医学杂志,2018,28:31-36. 17 Kurosaki A,Hasegawa K,Kato T,et al.Serum folate receptor alpha as a biomarker for ovarian cancer:Implications for diagnosis,prognosis and predicting its local tumor expression.Int J Cancer,2016,138:1994-2002. 18 Song DG,Ye Q,Poussin M,et al.Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level.J Hematol Oncol,2016,9:56-68. 19 Yehuda G,Assaraf A,Christopher P,et al.The folate receptor as a rational therapeutic target for personalized cancer treatment.Drug Resist Updates,2014,17:89-95. 20 Miranda BNM,Fotoran WL,Canduri F,et al.Heterologous expression of Homosapiens alpha-folate receptors in E.coli by fusion with a trigger factor for enhanced solubilization.Protein Expr Purif,2018,142:75-80. 21 Peoples GE,Anderson BW,Fisk B,et al.Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides.Ann Surg Oncol,1998,5:743 -50. 22 Clifton GT,Sears AK,Clive KS,et al.Folate receptor α:a storied past and promising future in immunotherapy.Hum Vaccin,2011,7:183-90. 23 Patel NR,Piroyan A,Ganta S,et al.In Vitro and in vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.Cancer Biol Ther,2018,19:554-564. 24 Bandara NA,Bates CD,Lu Y,et al.Folate-hapten-mediated immunotherapy synergizes with vascular endothelial growth factor receptor inhibitors in treating murine models of cancer.Mol Cancer Ther,2017,16:461-468.
